Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits. The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. 

The global CNS biomarker market was estimated at $1.7 billion in 2011 and nearly $2 billion in 2012. The market is projected to reach $5.1 billion by the end of the forecast period of 2012 to 2017, representing a compound annual growth rate (CAGR) of 20.7%.

GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of neurodegenerative and psychiatric disease. It infers that brain diseases are resulted from disruption of synaptic structure and function.

  • Neurogenesis and repair
  • Studies on neuronal circuits
  • GABA , 5HT receptors and its neuronal development
  • Synaptopathy in neurodegenerative diseases and ageing
  • Manipulation of ion channels by drugs

Related Conference of Molecular Neuropharmacology

June 20-21, 2016

4th African Pharma Congress

Cape Town, South Africa
July 11-13, 2016

6th Asia-Pacific Pharma Congress

Kuala Lumpur, Malaysia
July 14-16, 2016

5th Global Pharmacists Annual Meeting

Brisbane, Australia
July 14-15, 2016

International Pharmacy Conference

Philadelphia, PA, USA
July 18-20, 2016

5th Annual European Pharma Congress

Berlin,Germany
August 08-10, 2016

3rd World Congress on Pharmacology

Birmingham, UK
August 11-13, 2016

International Conference on Anatomy and Physiology

Holiday Inn Birmingham City Centre, Birmingham,UK
September 28-30, 2016

6th Pharmacovigilance Congress

Toronto, Ontario, Canada
August 22-24, 2016

2nd International Conference on Clinical Trials

Philadelphia, Pennsylvania, USA
August 22-24, 2016

7th Annual Global Pharma Summit

New Orleans, Louisiana, USA
September 05-07, 2016

Drug Formulation & Bioavailability Congress

Beijing, China
September 14-16, 2016

4th Global Experts Meeting on Neuropharmacology

San Antonio, Texas, USA
October 03-04, 2016

International Conference on Pain Research & Management

Vancouver, Canada
October 10-12, 2016

8th Annual Pharma Middle East Congress

Dubai, UAE
Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Conference on Clinical Pharmacy

Las Vegas, Nevada, USA
Nov 07-09, 2016

World Pharma Congress

Las Vegas, Nevada, USA
March 6-8, 2017

8th Global Pharmacovigilance Summit

Brisbane, Australia
March 27-29, 2017

International Conference on Medical Devices

Orlando, USA
May 25-26, 2017

World Congress on Biotherapeutics

Mexico, USA
June 12-14, 2017

World Congress on Controlled/ Sustained Release Formulations

Amsterdam, Netherlands
August 14-16, 2017

8th Asian Biosimilars Congress

Japan
Sep 25-27, 2017

Annual Pharmaceutical Analysis Conference

Vienna, Austria
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France

Molecular Neuropharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in